About Ontrak, Inc. 
Ontrak, Inc.
Pharmaceuticals & Biotechnology
Ontrak, Inc., formerly Catasys, Inc., is an artificial intelligence (AI)-powered and telehealth-enabled, virtualized outpatient healthcare treatment company. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren’t getting the care they need. The Company’s integrated, technology-enabled OnTrak solution, which is designed to identify and treat members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. OnTrak integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness.
Company Coordinates 
Company Details
2120 COLORADO AVE, SUITE 230 , SANTA MONICA CA : 90404
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 2 Schemes (0.56%)
Foreign Institutions
Held by 5 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Terren Peizer
Chairman of the Board, Chief Executive Officer, Director
Ms. Katherine Quinn
Director
Mr. Richard Berman
Independent Director
Mr. Gustavo Giraldo
Independent Director
Mr. Robert Rebak
Independent Director
Ms. Diane Seloff
Independent Director
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Mar 2025)
Net Profit:
-7 Million
Pharmaceuticals & Biotechnology
USD 0 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
1.19
-601.03%
0.02






